{"id":"W1990220334","doi":"10.1182/blood-2014-04-568329","title":"Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Comprehensive Cancer Network","keywords":"Bortezomib; Medicine; AL amyloidosis; Amyloidosis; Internal medicine; Multiple myeloma; Primary systemic amyloidosis; Surgery; Phases of clinical research; Gastroenterology; Progression-free survival; Clinical trial; Immunoglobulin light chain; Chemotherapy; Immunology; Systemic disease; Immunopathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003764892,0.0005980252,0.001786384,0.0005715771,0.0010982,0.0009134785,0.0004575982,0.0007802597,0.002094474],"category_scores_gemma":[0.001802947,0.0002527531,0.0008865526,0.000570266,0.0003892707,0.000496526,0.0005453939,0.001428278,0.0006547575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008253948,"about_ca_system_score_gemma":0.0008029002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001445583,"about_ca_topic_score_gemma":0.002703271,"domain_scores_codex":[0.9989574,0.0003052267,0.00007770573,0.0001749937,0.000238366,0.0002461686],"domain_scores_gemma":[0.9977823,0.0003561917,0.0003560704,0.0002546434,0.0004238877,0.000826865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.230972,0.02458376,0.4459749,0.0008394239,0.004073831,0.002610292,0.0005617655,0.002978951,0.03407567,0.0002777275,0.01688659,0.2361651],"study_design_scores_gemma":[0.03582911,0.1848566,0.7442189,0.0001490025,0.003138633,0.002770383,0.0001800474,0.00181826,0.007605995,0.0003582792,0.01900826,0.00006667851],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878805,0.004973186,0.0007077067,0.000205785,0.00007996726,0.0005435771,0.002548263,0.0000645523,0.00299648],"genre_scores_gemma":[0.9822581,0.0007964104,0.0005346093,0.0008186993,0.0001106691,0.0005037301,0.01263792,0.00002234046,0.002317499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003764892,"threshold_uncertainty_score":0.01991093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01601742525624578,"score_gpt":0.2702569067322985,"score_spread":0.2542394814760527,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}